Ligand validation:3HZS

M0E: MOENOMYCIN

M0E is a Ligand Of Interest in 3HZS designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3HZS_M0E_A_901	75%	25%	0.093	0.94	1.4	1.8	11	22	2	4	92%	0.9174
6FTB_M0E_A_301	46%	84%	0.154	0.891	0.19	0.56	-	4	12	0	100%	0.9478
3VMA_M0E_A_901	41%	9%	0.142	0.908	1.99	2.64	21	53	5	0	71%	0.7064
3FWL_M0E_A_901	27%	43%	0.191	0.893	0.94	1.32	3	11	8	0	71%	0.7064
5HLB_M0E_A_901	26%	2%	0.161	0.854	3.19	3.54	37	54	7	0	71%	0.7064
3VMR_M0E_A_901	15%	4%	0.236	0.84	2.89	2.96	33	69	11	0	77%	0.7706

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.